Oxford Brain Diagnostics Ltd

📍 Oxford, United Kingdom🗓 Founded 2019👥 18 employees💰 Last funded May 2019
Medical and Diagnostic Laboratories🌐 oxfordbraindiagnostics.com
Website LinkedIn
Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
3
Frequently asked questions
Who invested in Oxford Brain Diagnostics Ltd?
Oxford Brain Diagnostics Ltd has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Oxford Brain Diagnostics Ltd last raise funding?
The most recent investment in Oxford Brain Diagnostics Ltd recorded on gritt.io was in May 2019.
When was Oxford Brain Diagnostics Ltd founded?
Oxford Brain Diagnostics Ltd was founded in 2019.
What industry is Oxford Brain Diagnostics Ltd in?
Oxford Brain Diagnostics Ltd operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is Oxford Brain Diagnostics Ltd based?
Oxford Brain Diagnostics Ltd is headquartered in Oxford, United Kingdom.